GB1246727A - Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids - Google Patents
Therapeutic hypotensive compositions comprising 5-alkylpicolinic acidsInfo
- Publication number
- GB1246727A GB1246727A GB699769A GB699769A GB1246727A GB 1246727 A GB1246727 A GB 1246727A GB 699769 A GB699769 A GB 699769A GB 699769 A GB699769 A GB 699769A GB 1246727 A GB1246727 A GB 1246727A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- therapeutic
- pharmaceutically acceptable
- acids
- picolinic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,246,727. Compositions comprising picolinic acid derivatives. ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI. 10 Feb., 1969, No. 6997/69. Heading A5B. [Also in Division C2] A therapeutic composition, in unit dosage form, having hypotensive activity comprises 5-butylpicolinic acid or 5-pentyl-picolinic acid and pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable diluent or carrier, the active ingredient being present in an amount of 20-250 mg. per unit dose of the composition. The compositions may be in a form suitable for oral administration or in the form of a suppository. The picolinic acids may for example be present as the calcium salt or the hydrochloride.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB699769A GB1246727A (en) | 1969-02-10 | 1969-02-10 | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids |
FR6940314A FR2030389B1 (en) | 1969-02-10 | 1969-11-24 | |
NL6918507A NL6918507A (en) | 1969-02-10 | 1969-12-10 | |
BE743076D BE743076A (en) | 1969-02-10 | 1969-12-12 | |
DE19702005255 DE2005255C3 (en) | 1969-02-10 | 1970-02-05 | Use of Ca-5-butyl picolinate and / or Ca-5-pentyl picolinate for the production of an antihypertensive medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB699769A GB1246727A (en) | 1969-02-10 | 1969-02-10 | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1246727A true GB1246727A (en) | 1971-09-15 |
Family
ID=9824661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB699769A Expired GB1246727A (en) | 1969-02-10 | 1969-02-10 | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE743076A (en) |
DE (1) | DE2005255C3 (en) |
FR (1) | FR2030389B1 (en) |
GB (1) | GB1246727A (en) |
NL (1) | NL6918507A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487761A (en) * | 1982-04-05 | 1984-12-11 | Merck & Co., Inc. | Dopamine β-hydroxylase inhibitors |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2108847A1 (en) * | 1970-10-06 | 1972-05-26 | Zaidan Hojin Biseibutsu | 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors |
FR2132601A1 (en) * | 1971-04-07 | 1972-11-24 | Microbial Chem Res Found | Anti-alcoholic compsns contng calcium 5-buty |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB157368A (en) * | 1916-09-15 | 1922-04-10 | Victor Kaplan | Improvements in rotor wheels for water turbines with wing-like blades |
-
1969
- 1969-02-10 GB GB699769A patent/GB1246727A/en not_active Expired
- 1969-11-24 FR FR6940314A patent/FR2030389B1/fr not_active Expired
- 1969-12-10 NL NL6918507A patent/NL6918507A/xx not_active Application Discontinuation
- 1969-12-12 BE BE743076D patent/BE743076A/xx not_active IP Right Cessation
-
1970
- 1970-02-05 DE DE19702005255 patent/DE2005255C3/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487761A (en) * | 1982-04-05 | 1984-12-11 | Merck & Co., Inc. | Dopamine β-hydroxylase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
BE743076A (en) | 1970-05-14 |
DE2005255A1 (en) | 1970-09-03 |
DE2005255C3 (en) | 1981-05-14 |
DE2005255B2 (en) | 1980-06-26 |
FR2030389A1 (en) | 1970-11-13 |
FR2030389B1 (en) | 1973-06-08 |
NL6918507A (en) | 1970-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL74707A (en) | Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation | |
MY102038A (en) | 4-substituted androstendione derivatives and process for their preparation | |
ES8506615A1 (en) | N-aryl-alpha-amino-carboxamides. | |
ATE158504T1 (en) | EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS | |
GB1418208A (en) | Pharmaceutical compositions | |
BG60101B2 (en) | Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le | |
HUT50334A (en) | Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient | |
ES427079A1 (en) | Phenothiazine derivatives, compositions thereof and methods of preparation thereof | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
GB1246727A (en) | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids | |
MY101747A (en) | Dihydroorotic acids derivative, processes for preparing the same | |
ES8502076A1 (en) | 3-Beta-(3'-(carboxypropionyloxy))-ursa-9(11),12-dience-28-carboxylic acid and its salts, process for its preparation and medicines containing these compounds. | |
ES2000681A6 (en) | Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use. | |
GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
DE3380294D1 (en) | Pharmaceutical compositions in oral dosage form | |
GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
GB1424611A (en) | Pharmaceutical compositions | |
IE36780B1 (en) | New pharmaceutical preparations | |
GB1375806A (en) | ||
ES8502439A1 (en) | 3-Deazaguanine sulphonic acid salts. | |
IE43848L (en) | Pharmaceutical compositions | |
ES8304925A1 (en) | New peptide, process for preparation thereof and use thereof. | |
ES8505644A1 (en) | S-Carboxymethylcysteine derivatives having a therapeutic activity, process for their preparation and pharmaceutical compositions which contain them | |
GB1386927A (en) | Preparations for combatting swine dysentery | |
GB1332904A (en) | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids |